An alternative theory of tissue specificity by tumor promotion of okadaic acid in glandular stomach of SD rats.
To challenge the theory of tissue specificity of tumor promoters, the biochemical and tumor promoting effects of okadaic acid (OA), a potent tumor promoter on mouse skin, were studied in the mucosa of rat glandular stomach. OA strongly inhibited protein phosphatases 1 and 2A, and increased 4-fold the phosphorylation of elongation factor 2 in vitro in the mucosa. Intubation of 10 micrograms (12.4 nmol) OA induced ornithine decarboxylase in the mucosa. Tumor promotion of OA was studied in the glandular stomach initiated with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) in a two-stage carcinogenesis experiment. OA in drinking water, 10 micrograms (12.4 nmol) per rat per day from weeks 9-55 of the experiment, and 20 micrograms (24.8 nmol) from weeks 56-72, significantly enhanced development of the neoplastic changes in the glandular stomach (P < 0.05). The neoplastic changes included adenomatous hyperplasias and adenocarcinomas, both of which correspond to papillomas and carcinomas in a two-stage mouse skin carcinogenesis experiment. The percentages of neoplastic change-bearing rats of the groups treated with MNNG plus OA, MNNG alone or OA alone were 75.0, 46.4 and 0% respectively. OA enhanced tumorigenesis in the MNNG-initiated glandular stomach of rats through the same mechanisms of action as in mouse skin. The OA pathway mediated through inhibition of protein phosphatases 1 and 2A is applicable to various organs as a general mechanism of tumor promotion.
Suganuma
M
M
National Cancer Center Research Institute, Tokyo, Japan.
Tatematsu
M
M
Yatsunami
J
J
Yoshizawa
S
S
Okabe
S
S
Uemura
D
D
Fujiki
H
H
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002273:Carcinogens / Q000494:pharmacology* / Q000633:toxicity; D004790:Enzyme Induction; D004988:Ethers, Cyclic / Q000494:pharmacology* / Q000633:toxicity; D005260:Female; D005753:Gastric Mucosa / Q000201:enzymology; D008297:Male; D008769:Methylnitronitrosoguanidine; D019319:Okadaic Acid; D009928:Organ Specificity; D009955:Ornithine Decarboxylase / Q000096:biosynthesis; D010749:Phosphoprotein Phosphatases / Q000037:antagonists & inhibitors / Q000378:metabolism; D051381:Rats; D011916:Rats, Inbred F344; D017207:Rats, Sprague-Dawley; D013270:Stomach / Q000187:drug effects* / Q000201:enzymology; D013274:Stomach Neoplasms / Q000139:chemically induced* / Q000201:enzymology
D002273:Carcinogens; D004988:Ethers, Cyclic; D008769:Methylnitronitrosoguanidine; D019319:Okadaic Acid; D010749:Phosphoprotein Phosphatases; D009955:Ornithine Decarboxylase